Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
7/18/24 LG Chem (051910:KS) Fotivda for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
7/11/24 Acurx Pharmaceuticals (ACXP) Ibezapolstat for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Subscribers Only Subscribers Only Subscribers Only
7/10/24 SoVarGen Paxalisib for Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)) Subscribers Only Subscribers Only Subscribers Only
7/10/24 OKYO Pharma (OKYO) OK-101 for Dry Eye (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
7/8/24 HilleVax (HLVX) HIL-214 for Norovirus Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/01/25 - 04/30/24 Subscribers Only Subscribers Only Progress Update - Product Launch
07/23/24 Subscribers Only Subscribers Only Trial Data - Top-Line Results
07/23/24 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Brief
07/24/24 Subscribers Only Subscribers Only Trial Data - Updated Results
07/24/24 Subscribers Only Subscribers Only Trial Data - Updated Results